发明申请
- 专利标题: Chemosensory Receptor Ligand-Based Therapies
- 专利标题(中): 化学感应受体配体疗法
-
申请号: US15289713申请日: 2016-10-10
-
公开(公告)号: US20170020829A1公开(公告)日: 2017-01-26
- 发明人: Alain D. BARON , Nigel R.A. BEELEY , Mark S. FINEMAN
- 申请人: ELCELYX THERAPEUTICS, INC.
- 主分类号: A61K31/155
- IPC分类号: A61K31/155 ; A61K45/06
摘要:
Provided herein are methods for treating conditions associated with a chemosensory receptor, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a chemosensory receptor ligand, such as a bitter receptor ligand. Also provided herein are chemosensory receptor ligand compositions, including bitter receptor ligand compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.
公开/授权文献
- US09962344B2 Chemosensory receptor ligand-based therapies 公开/授权日:2018-05-08
信息查询